메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
한남대학교 과학기술법연구원 과학기술법연구 과학기술법연구 제17권 제2호
발행연도
2011.1
수록면
3 - 45 (43page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
On 16 October 2010, a new international treaty, the Nagoya–Kuala Lumpur Supplementary Protocol on Liability and Redress to the Cartagena Protocol on Biosafety, was adopted at one of the largest intergovernmental meetings ever held on the safe use of modern biotechnology. The adoption of the new treaty was generated from the end of the five-day meeting of the governing body of the Cartagena Protocol on Biosafety (known as the Conference of the Parties serving as the meeting of the Parties to the Protocol or COP-MOP 5) and concluded six years of negotiations. The new supplementary Protocol provides international rules and procedure on liability and redress for damage to biodiversity resulting from living modified organisms (LMO). The term "liability" is normally related with the obligation under the applicable law to provide for compensation for damage resulting from an action for which that person is deemed to be responsible. Liability and redress in the context of the Protocol concerns the question of what would happen if the transboundary movement of living modified organisms (LMOs) has caused damage. The issue of liability and redress for damage resulting from the transboundary movements of LMOs was one of the themes on the agenda during the negotiation of the Biosafety Protocol. The negotiators were, however, unable to reach any consensus regarding the details of a liability regime under the Protocol. The matter was, nevertheless, considered both critical and urgent. As a result, an enabling clause to that effect was included in the final text of the Protocol. The Protocol itself is not perfect for parties to lead their legislation. There are many problems to legislate this Protocol as new act for LMO's damage. In this regard, legislator should focus on the purpose of this Protocol and deliberate its workable legal mechanism. Legislator should study distinctive features of LMO in legislation process and adopt effective civil procedure, civil liability system, buren of proving and financial security. It is anticipated that we will have amounts of obstacles in legislating this Protocol as effective and workable act for LMO's damage. However, legislator should endeavor to establish and develop this Protocol as enforcing act for the safe use of LMO and the development of modern biotechnology.

목차

등록된 정보가 없습니다.

참고문헌 (44)

참고문헌 신청

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0